Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 230 results for "Acute Myeloid Leukemia (AML)".

Thumbnail for Immune Cell Type Abundance Predicts Survival of Pediatric Acute Myeloid Leukemia Patients at Diagnosis

AML - 781

Immune Cell Type Abundance Predicts Survival of Pediatric Acute Myeloid Leukemia Patients at Diagnosis

Jaclyn Shaw

Poster Presenter: Jaclyn Shaw

Thumbnail for Upfront Allogeneic Stem Cell Transplantation With Individualized Venetoclax-Based Conditioning in MECOM-Rearranged Acute Myeloid Leukemia: A Single-Center Retrospective Study

AML - 783

Upfront Allogeneic Stem Cell Transplantation With Individualized Venetoclax-Based Conditioning in MECOM-Rearranged Acute Myeloid Leukemia: A Single-Center Retrospective Study

Milda Mikalonyt?

Poster Presenter: Milda Mikalonyt?

Previous 1...20 21 22 23 24 25 26 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Real-World Treatment Patterns and Outcomes With Olutasidenib After Venetoclax in IDH1-Mutated Acute Myeloid Leukemia Using Electronic Health Record Data

AML - 784

Real-World Treatment Patterns and Outcomes With Olutasidenib After Venetoclax in IDH1-Mutated Acute Myeloid Leukemia Using Electronic Health Record Data

Yasmin Abaza

Poster Presenter: Yasmin Abaza

Thumbnail for Is MRD Negativity a Valid Surrogate for Overall Survival in RandomizedTrials of Acute Myeloid Leukemia?

AML - 791

Is MRD Negativity a Valid Surrogate for Overall Survival in RandomizedTrials of Acute Myeloid Leukemia?

Vivian Reis Ferrarez

Poster Presenter: Vivian Reis Ferrarez

Thumbnail for Treatment Patterns and Outcomes with Olutasidenib After Venetoclax in IDH1-Mutated AML Using Real-World Data from Chart Review

AML - 792

Treatment Patterns and Outcomes with Olutasidenib After Venetoclax in IDH1-Mutated AML Using Real-World Data from Chart Review

Amber Thomasson

Poster Presenter: Amber Thomasson

Thumbnail for Efficacy and Safety of Venetoclax Combined with Hypomethylating Agents in Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis

AML - 806

Efficacy and Safety of Venetoclax Combined with Hypomethylating Agents in Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis

Ahmad Shafi Antar

Poster Presenter: Ahmad Shafi Antar

Thumbnail for Optimizing Low-Intensity Therapeutic Strategies in Older Acute Myeloid Leukemia: A Systematic Review and Network Meta-Analysis

AML - 811

Optimizing Low-Intensity Therapeutic Strategies in Older Acute Myeloid Leukemia: A Systematic Review and Network Meta-Analysis

Ahmad Shafi Antar

Poster Presenter: Ahmad Shafi Antar

Thumbnail for ALOX5AP as an Oncogenic Regulator in Acute Myeloid Leukemia: Insights from Expression Profiling, DNA Methylation, and Molecular Pathway Analysis

AML - 828

ALOX5AP as an Oncogenic Regulator in Acute Myeloid Leukemia: Insights from Expression Profiling, DNA Methylation, and Molecular Pathway Analysis

Archit Goel

Poster Presenter: Archit Goel

Thumbnail for Comparison of Ivosidenib- and Venetoclax-Based Treatment Sequencing and Outcomes in Patients With mIDH1 AML: A Real-World Study

AML - 829

Comparison of Ivosidenib- and Venetoclax-Based Treatment Sequencing and Outcomes in Patients With mIDH1 AML: A Real-World Study

Vanessa Kennedy

Poster Presenter: Vanessa Kennedy

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors